BTG PLCCompany Profile and Tech Intelligence Report, 2018
14:04
Dr Louise Makin, CEO of BTG plc., interview at UWE Bristol
2:03
DXTV #113| Mistras Group, Michael Page Int, BTG Plc
3:12
BTG History
BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changed its name on 27 May 1998. BTG was a constituent of the FTSE 250 Index until it was acquired by Boston Scientific in August 2019.